Clinical independence is not a checkbox; it is the foundation that determines whether a healthcare platform can grow sustainably while adhering to the mandate to serve patients. In this episode of "Counsel That Cares," Healthcare Transactions attorney John Saran and oral and maxillofacial surgeon Robert "Bobby" McNeill discuss the increasing focus on the intersection of private equity investment and independent clinical judgment amid accelerated industry consolidation and heightened regulatory scrutiny. Dr. McNeill brings a distinct perspective combining professional medical and dental experience, an MBA in healthcare management, service on the Texas State Board of Dental Examiners and current law school studies. With this background, he emphasizes that even though private capital brings critical infrastructure, technology and operational support, its value is durable only when clinicians retain true authority over patient care, not only in legal documents but also in day-to-day practice, where metrics, financial incentives and emerging technologies such as artificial intelligence (AI) can subtly shape decisions. Throughout the conversation, both speakers reiterate that when clinical independence is not meaningfully preserved in practice, it can affect patient trust, regulatory exposure and overall platform stability.

False Claims Act enforcement in healthcare is accelerating, and providers cannot afford to wait to react until the government comes calling. In this episode of "Counsel That Cares," litigation attorneys Meredith Auten and Jessica Sievert discuss the U.S. Department of Justice's new National Fraud Enforcement Division, record enforcement recoveries and the sectors drawing the sharpest scrutiny. They point to concrete examples already shaping the landscape involving Medicare Advantage, drug pricing, medical necessity, wound care, speaker programs and digital health. Ms. Auten and Ms. Sievert also talk about the government's expanded use of artificial intelligence and data analytics to identify fraud patterns and drive cases.

Telehealth innovation succeeds only when compliance discipline matches the pace of growth. In this episode of Counsel That Cares, Holland & Knight healthcare regulatory attorney Shalyn Watkins and Receptive CEO Amber Gill examine how modern telehealth platforms scale nationwide while navigating fragmented regulations that can differ drastically from jurisdiction to jurisdiction. Ms. Gill explains how Receptive reduces friction for patients by separating platform infrastructure from clinical decision-making, while Ms. Watkins details how corporate practice of medicine rules, data privacy laws and controlled substance regulations require careful state-by-state analysis. The discussion delivers a clear takeaway for telehealth providers and the legal professionals advising them: In healthcare disputes and enforcement actions, licensure privacy and regulatory design often determine whether innovative care models withstand scrutiny.